‘Gentiva’ Formed As Humana Closes Personal Care Divestiture
Humana Inc. (NYSE: HUM) announced Thursday that it has completed its divestiture of Kindred at Home’s hospice and personal care divisions. Clayton, Dubilier & Rice […]
Humana Inc. (NYSE: HUM) announced Thursday that it has completed its divestiture of Kindred at Home’s hospice and personal care divisions. Clayton, Dubilier & Rice […]
Two large private equity firms have made under-the-radar investments in the self-directed, at-home care enabler Public Partnerships (PPL). That’s according to a new report from […]
Yet another massive retailer is inching closer to buying a company that is focused on the home as a setting of care. CVS Health Corp. […]
The Richmond, Virginia-based Care Advantage has acquired National Home Healthcare, which is based in Herndon, Virginia. National Home Healthcare marks the 16th acquisition Care Advantage […]
Pfizer’s reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT) has been confirmed, with the $68.50-per-share deal valuing GBT at $5.4 billion. […]
Pfizer is on the brink of announcing a deal to buy Global Blood Therapeutics (GBT) and its oral therapy Oxbryta for sickle cell disease for […]
What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in […]
Less than three years after being spun out of Oxford University, privately-held biotech MiroBio is heading for a takeover by Gilead Sciences in a $405 […]
Ten months after ChemoCentryx scored an unexpected FDA approval for autoimmune disease therapy Tavneos, Amgen has swooped in with a $3.7 billion bid to buy […]
Retail and technology giant Amazon (Nasdaq: AMZN) last month announced plans to acquire primary care innovator One Medical for an astounding $3.9 billion. The transaction […]
Just a year and a half after going live on the public market, Signify Health Inc. (NYSE: SGFY) is reportedly exploring strategic alternatives, including a […]
The Biden administration has shown time and again its commitment to home- and community-based services. And Addus HomeCare Corporation (Nasdaq: ADUS) is beginning to reap […]
Laboratory Corp of America (Labcorp) has announced that it plans to separate its clinical development business into an independent, publicly-traded contract research organisation (CRO). The […]
Amazon has accelerated its expansion into the healthcare sector with an all-cash deal to acquire One Medical, a US group that provides virtual and in-person […]
Amazon (Nasdaq: AMZN) announced plans on Wednesday to acquire the primary care provider One Medical (Nasdaq: ONEM) for a price tag of $3.9 billion. Once […]
Several digital health darlings that have raised tens of millions of dollars over the past few years are now scrambling to survive. Those focused on […]
Novartis said this morning that it remains on course to make a decision on the future of its generics business Sandoz by the end of […]
UnitedHealth Group Inc. (NYSE: UNH) is still awaiting its pending deal of the home health giant LHC Group Inc. (Nasdaq: LHCG) to close. In the […]
Illumina’s attempt to prevent the European Commission from carrying out an antitrust review of its $8 billion takeover last year of cancer diagnosis firm Grail […]
A recent and encouraging trend in the home-based scare space has been the use of EMS workers as fill-ins when there are staff shortages. When […]
La Jolla Pharmaceuticals dreams of building a lucrative business from its stable of drugs used in infectious diseases never really paid off, and the company […]
In an under-the-radar move, UnitedHealth Group (NYSE: UNH) has been combining Optum Health assets with Red Ventures’ health care portfolio to create a new consumer […]
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development […]
The rumour that Merck & Co is preparing to make a sizeable offer to buy cancer specialist Seagen won’t go away. The latest report – […]
Last month, UnitedHealth Group (NYSE: UNH) and LHC Group Inc. (Nasdaq: LHCG) each received a request from the Federal Trade Commission (FTC) for more information […]
AstraZeneca has signed a deal to buy US biotech TeneoTwo in a deal worth up to $1.27 billion that will boost its position therapies for […]
Walgreens Boots Alliance (Nasdaq: WBA) remains committed to its growth strategy, one that includes the continued incorporation of home-based care. The company is focused particularly […]
Rising deal premiums and shrinking profit margins are threatening the sustainability of the traditional approach to mergers and acqusitions, according to a report by Accenture. […]
The revamp of French drugmaker Ipsen has continued with a takeover agreement for US counterpart Epizyme and its cancer therapy Tazverik, in a deal valued […]
With the uncertainty surrounding the U.S. Centers for Medicare & Medicaid Services’ (CMS) new proposed payment rule, buyers and sellers in the M&A industry will […]
Over 27 million of LHC Group’s (Nasdaq: LHCG) 31 million shareholders participated in a vote Tuesday regarding the company’s pending deal with UnitedHealth Group (NYSE: […]
Speculation that Merck & Co may be preparing a $30 billion takeover bid for Seagen – bolstering its oncology ambitions – has the biopharma community […]
Canadian wireless network carrier Telus has agreed a C$2.9 billion ($2.2 billion) deal to acquire LifeWorks, a digital health specialist that will bulk up the […]
AstraZeneca is rumoured to be considering a bid to take control of its longstanding partner Mereo BioPharma, according to a report in The Times, which […]
Boehringer Ingelheim must like what it has seen in its two-year-old R&D collaboration with Trutino Biosciences to develop cytokine therapies – it has just taken […]
By leveraging improved recruitment numbers and the surplus of resources from state governments, leaders with Addus HomeCare Corporation (Nasdaq: ADUS) are hoping the tail end […]
The private equity-based HomeFirst Home Healthcare is cognizant of the sub-par rates that Medicare Advantage (MA) plans pay for home health services, as are nearly […]
After multiple years of record-breaking M&A activity, home health consolidators are now starting to show an increased interest in organic growth. While the approach to […]
Bristol-Myers Squibb’s all-cash offer for Turning Point Therapeutics – which values the biotech at $4.1 billion – bolsters its position in precision oncology and gives […]
GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next month, with a listing for the new […]
GlaxoSmithKline has agreed a $3.3 billion takeover of US biotech Affinivax, buying a pneumococcal vaccine candidate that is aiming to break into a market that […]
Home health and personal care services provider Amedisys Inc. (Nasdaq: AMED) is experimenting with a new model that better fits the Medicare Advantage-heavy environment of […]
In the animal kingdom, there’s strength in numbers, especially among creatures that find themselves toward the bottom of the food chain. This concept is also […]
While the appetite for home health and home care M&A dealmaking remains strong, other health care subsectors are catching up. Coming off a record-breaking 2021 […]
Los Angeles-based 24 Hour Home Care will increase its client census by over 16% in the Long Beach and South Bay communities after acquiring home […]
Several hospital telehealth vendors enjoyed great success in 2020 as they benefitted from unprecedented demand for their IT and services during the pandemic. But as […]
HealthQuest Capital Team What You Should Know: – HealthQuest Capital, a sector specialist capital firm focused on companies optimizing value in healthcare, today announced the […]
Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has maintained a disciplined approach to raising wages since it went public. Its gross margins are driven by the […]
The prevalence of mental and behavioral health conditions has been on the rise in recent decades, further aggravated by the pandemic in the last two […]
The home health segment of The Pennant Group Inc. (Nasdaq: PNTG), to some extent, carried the company at the beginning of 2022. In the first […]
Pfizer is turning to M&A to get its next blockbuster, buying Biohaven six months after the two companies began a commercialization pact centered on the […]
Not content with a $1.2 billion licensing deal for Biohaven Pharma’s oral migraine therapy rimegepant, Pfizer has just offered to buy the company outright – […]
When the Germans bombed England during World War II, “remote misses” ended up giving Londoners “survivor exhilaration,” which resulted in boosted morale as opposed to […]
Following a record-breaking year for home care, home health and hospice M&A, deal volume took a dive in the first quarter of 2022. In fact, […]
Staffing is almost ubiquitously considered the toughest challenge in both home health and home care. A parallel issue that is often considered far less, however, […]
Humana Inc. (NYSE: HUM) has agreed to sell 60% of its hospice and personal care assets from Kindred at Home to the private equity firm […]
Addus HomeCare Corporation (Nasdaq: ADUS) announced Wednesday that it has named a new EVP and chief development officer in Cliff Blessing, who had previously served […]
Regeneron has agreed an all-cash deal to acquire CheckMate Pharmaceuticals, adding immune activator vidutolimod to its cancer immunotherapy pipeline and ending a barren spell for […]
Amedisys Inc. (Nasdaq: AMED) has been vocal about leaning into the opportunities that offering higher-acuity care in the home will bring. That has also had […]
One of the larger home care organizations in the U.S., Help at Home, has made a significant leap in expanding its reach. The company announced […]
UnitedHealth Group (NYSE: UNH) is moving toward value-based care at a faster pace than even it originally imagined. And that’s partly because of the success […]
Pfizer’s Australian unit has tabled an offer to buy ResApp Health and its smartphone apps for the management and diagnosis of respiratory diseases in a […]
GlaxoSmithKline has agreed a deal to buy Sierra Oncology and its lead drug momelotinib for anaemia associated with the blood cancer myelofibrosis, sending the US […]
LazyCo, the wearables company behind the Aina Ring that can be used to interface with a smartphone, has been snapped up by digital fitness and […]
The Chicago-based Vistria group is one of the most active private equity firms in the home-based care space. It has the providers – on the […]
What You Should Know: – Conceive, a New York City-based femtech startup on a mission to transform fertility, today that the public beta of its […]
Last week, UnitedHealth Group (NYSE: UNH) revealed that it’s buying aging-in-place giant LHC Group Inc. (Nasdaq: LHCG) and combining the provider with its Optum business. […]
Pfizer is looking to follow its vaccine/oral antiviral combination that has proved so profitable in COVID-19 with a similar approach in respiratory syncytial virus (RSV). […]
The future of home-based care will very likely be dominated by managed care, according to a 40-year veteran of the space. Mark Heaney, CEO and […]
The pace hasn’t been as aggressive as some expected, but the home health industry has been undergoing a wave of consolidation over the past several […]
When Advocate Aurora Enterprises — a subsidiary of Advocate Aurora Health – acquired the home care provider Senior Helpers around this time last year, it […]
An emerging home health provider is back on the M&A trail for the first time in 2022. The Tyler, Texas-based Choice Health at Home has […]
During, and in the run-up to, HIMSS earlier this month there were several announcements from US EHR vendors that will shake up the US EHR […]
German injectable medicines specialist Fresenius Kabi has made a pair of deals to kickstart its new strategic direction, including a majority stake in mAbxience that […]
LHC Group Inc. (Nasdaq: LHCG) began in 1994 as a single home health agency, co-founded by husband-and-wife duo Keith and Ginger Myers, the provider’s first […]
LetsGetChecked, a specialist in at-home diagnostic testing, has added genomics to its technology base with the acquisition of Veritas for an undisclosed amount. The company […]
Trinity Health at Home – one of the largest home health providers in the country – plans to expand its private-duty footprint and be more […]
UnitedHealth Group (NYSE: UNH) has agreed to buy LHC Group (Nasdaq: LHCG). The deal reportedly values LHC Group at “more than” $5.5 billion. The plan […]
Home care franchise giant Seniors Helpers entered this year with big ambitions, partly fueled by its April 2021 acquisition by Advocate Aurora Enterprises. Those ambitions […]
Traditions Health announces Serenity Health Management acquisition Traditions Health continues to be acquisitive. The College Station, Texas-based home health and hospice agency announced the acquisition […]
LHC Group Inc. (Nasdaq: LHCG) established its first home health joint venture with Louisiana’s Opelousas General Hospital in 1998. Since then, LifePoint Health, Christus Health […]
As a provider of home health, hospice and senior living, the Pennant Group Inc. (Nasdaq: PNTG) still sees value in all of the settings it […]
Encompass Health Corporation (NYSE: EHC) publicly appears to be moving forward with its plan to separate its $1.1 billion home health and hospice segment into […]
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient […]
Even though it has been hit hard by labor pressures, Addus HomeCare Corporation (Nasdaq: ADUS), believes it may have found ways to at least combat […]
Mergers & Acquisitions (M&A) Activity OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform OptimizeRx, a provider of point-of-care technology solutions helping patients start and […]
The home-based care provider Care Advantage is at somewhat of an inflection point. Last year, the private investment firm Searchlight Capital landed a majority stake […]
Humana Inc. (Nasdaq: HUM) has been one of the key home health players to watch over the past few years, an idea best illustrated by […]
Novartis may be planning to sell off its generics business Sandoz, but that hasn’t stopped it investing in the unit ahead of a decision on […]
Earlier this week, a report surfaced claiming that Advent International, Aveanna Healthcare Holdings (Nasdaq: AVAH) and at least a few other companies have “expressed interest” […]
Months of speculation finally ended in January when Encompass Health Corporation (NYSE: EHC) announced its home health and hospice segment would spin off as Enhabit […]
A lot changed for Signify Health Inc. (NYSE: SGFY) throughout 2021. One thing that has remained constant, though, is the organization’s push towards a value-based […]
Four years after spinning out from Belgium’s UCB, Syndesi Therapeutics and its SV2A modulator programme has been bought by AbbVie for $130 million upfront. The […]
India’s Biocon has expanded its pipeline of biosimilars with a $3.3 billion deal to acquire a portfolio of drugs from Viatris, the parent of its […]
LHC Group Inc. (Nasdaq: LHCG) executives believe that almost all of the company’s problems are short term in nature. Nonetheless, those problems cost the business […]
Earlier this year, Five Star Senior Living changed its name to AlerisLife (Nasdaq: ALR) to reflect its significant organizational restructuring over the past two years. […]
Amedisys Inc. (Nasdaq: AMED) has entered into an agreement to acquire the home health assets of AssistedCare Home Health and RH Homecare Services, the latter […]
GlaxoSmithKline’s consumer health business will be named Haleon following its planned spinoff and listing on the London Stock Exchange later this year, according to the […]
In terms of business, providers are slowly beginning to move away from the strict distinctions of home health, home care and hospice. “These are separate […]
Equillium has announced another bolt-on deal to expand its pipeline tripling the size of its clinical pipeline to three drug candidates via a $329 million […]
When Brookdale Senior Living Inc. (NYSE: BKD) sold the majority of its home health assets to HCA Healthcare (NYSE: HCA) last year, health care insiders […]
Collegium Pharma has expanded its pain franchise though a deal to acquire BioDelivery Sciences International (BDSI), which has three FDA-approved drugs and a new migraine […]
Barb Jacobsmeyer’s takeover of Encompass Health’s (NYSE: EHC) home health and hospice segment took place during abnormal times. For starters, she was replacing a former […]
Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. If […]
Signify Health Inc. (NYSE: SGFY) announced its first acquisition on Thursday. The company signed an agreement to acquire Caravan Health, an accountable care organization (ACO) […]
Earlier this week, Axios reported that Humana Inc. (NYSE: HUM) is gearing up for a sale of Kindred at Home’s hospice business and seeking a […]
India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German […]
Novartis chief executive Vas Narasimhan has downplayed any chances of swift decision on the future of its generics business Sandoz, saying that a decision on […]
Amedisys Inc. (Nasdaq: AMED) has entered into an agreement to acquire Evolution Health, a Dallas-based provider of home health, hospice and infusion therapy services. The […]
French health wearables company Withings has agreed a deal to acquire 8fit, a German digital health company whose personalised workout and meal-planning app is used […]
Glooko has made a name for itself in digital health circles with its data management tools for diabetes patients, and has now added artificial intelligence […]
Dealmaking in 2021 for home-based care had its highs and lows. On an annual basis, home health, home care and hospice operators saw an overall […]
Recent rumours that Biogen was about to acquired by Samsung proved unfounded, but it turns out a deal has been in preparation. The South Korean […]
HCA Healthcare Inc. (NYSE: HCA) executives provided a brief update on the company’s home health and hospice operations Thursday. It was the first time the […]
The final numbers are in, and now it’s official – digital health companies raked in a massive $57.2 billion in funding last year, beating prior […]
Johnson & Johnson has said the impending spin-off of its consumer health division won’t stop it from “forging ahead” with M&A deals to expand its […]
LHC Group Inc. (Nasdaq: LHCG) executives have spent the past several months preparing for 2022, which President and COO Josh Proffitt describes as a year […]
This article is an exclusive feature available as a part of your subscription to HHCN + Choice Health at Home closes on $190 million credit […]
In December 2020, Encompass Health Corporation (NYSE: EHC) announced that it was “exploring strategic alternatives” for its home health and hospice segment. The company doubled […]
A young but rapidly growing in-home care business headquartered in Nashville, Tennessee, has secured millions of dollars to further fuel its expansion. The Atlanta-based Fulcrum […]
This article is an exclusive feature available as a part of your subscription to HHCN + Encompass Health, Saint Alphonsus announce joint venture Encompass Health […]
Activist investment firm Jana Partners is reportedly urging Encompass Health Corporation (NYSE: NYSE) to reconsider plans to spin off its home health and hospice segment […]
With all eyes focused on the home, it’s no exaggeration to say there were dozens of blockbuster in-home care acquisitions last year. But while all […]
The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to […]
Addus HomeCare Corporation (Nasdaq: ADUS) had intended to focus largely on home health and personal care acquisitions in 2022. But when a good hospice deal […]
Trella Health, a post-acute care data analytics company, announced Tuesday that it has acquired PlayMaker Health. “[The home-based care industry] has been asking for this,” […]
Push Doctor – a digital platform that virtually connects patients with GPs – has been acquired by private healthcare service provider Square Health for an […]
Last April, Addus HomeCare Corporation (Nasdaq: ADUS), Homecare Homebase (HCHB) and CellTrak announced they were teaming up to build “the industry’s first integrated, enterprise-level solution […]
The Richmond, Virginia-based home care provider Care Advantage Inc. went through a dealmaking lull during the early days of COVID-19. Unfortunately, the pandemic has not […]
After a busy year for digital health, four experts shared their predictions on which sectors will see the most M&A, and which companies are likely […]
The COVID-19 pandemic continued to dominate headlines in 2021, despite the collective desire for it to be gone by this past summer. But it didn’t […]
Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not […]
The public health emergency continued to have an impact on home-based care providers in 2021. It didn’t define the year, however. As the top Home […]
Sanofi has bolstered its immuno-oncology pipeline with a $1 billion agreement to acquire Amunix Pharma of the US – its fourth bolt-on deal of 2021. […]
The companies struck an all-cash deal on Monday for $95-per share. Oracle plans to add a voice interface to Cerner’s electronic health record system.
Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has completed its acquisition of Comfort Care, an adult home health and hospice company with operations in Alabama and […]
In a move to further cement its growing mobile diagnostics services, DispatchHealth announced Tuesday that it has acquired Dynamic Mobile Imaging. The financial terms of […]
Australian biotech group CSL has agreed a deal to acquire Swiss drugmaker Vifor Pharma in an all-cash deal that expands its speciality medicines business. If […]
Pfizer has found another use for the windfall profits it is making from it BioNTech-partnered COVID-19 vaccine, agreeing to buy Arena Pharma and its late-stage […]
Fortis Home Health & Hospice — Grant Avenue Capital’s home-based care buy-and-build initiative — has acquired Select Home Health. The financial terms of the deal […]
The home-based care M&A landscape has been very active over the last year. And as long as the publicly traded companies remain in good standing, […]
At CB Insights’ Future of Health Conference, Ginger CEO Russell Glass talked about how the company merged with Headspace to form a $3 billion mental […]
UK artificial intelligence specialist BenevolentAI has said it will float on the Amsterdam Euronext exchange in what is being touted as Europe’s largest ever special […]
An $8 billion attempt by two private equity companies to acquire Swedish rare disease specialist Sobi and take it back into private ownership has collapsed, […]
This article is an exclusive feature available as a part of your subscription to HHCN + Basically all of the publicly traded in-home care giants […]
When Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) became a public company earlier this year, it expressed the desire to expand its reach past pediatric home […]
Sanofi has added to its vaccine pipeline with an agreement to acquire Austria’s Origimm Biotechnology and its vaccine-based immunotherapy for people with acne. The French […]
Home care provider Executive Care recently received an investment from global investment firm The Riverside Company. The financial terms were not disclosed. Hackensack, New Jersey-based […]
Just a few weeks after Novartis revealed it was considering a sale of its generics business Sandoz, there are reports that a potential buyer has […]
CommonSpirit Health is in talks to transfer ownership of its home health operations in Minnesota and North Dakota to an undisclosed third party, according to […]
On the heels of a late-stage clinical trial failure, Vifor Pharma has moved to bolster its pipeline by acquiring Spain’s Sanifit and fell Swiss biotech […]
In 2018, the takeover of Athenahealth by Veritas Capital and Elliott Management for $5.5 billion was the biggest digital health transaction of the year, but […]
Shots: Novo Nordisk to acquire all outstanding shares of Dicerna common stock for $38.25/share in cash making a total equity value of ~$3.3B representing a […]
Danish drugmaker Novo Nordisk must like what it has seen in its two-year-old alliance with gene-silencing specialist Dicerna Pharma – it has just agreed to […]
Not so long ago, in-home care providers like Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) had to basically beg their payers for rate increases or additional […]
When Coltala Holdings acquired a stake in Choice Health at Home in June, its co-founders – Ralph Manning and Edward Crawford – were ecstatic. After […]
Shots: AcelRx signs a merger agreement to acquire Lowell for $32.5M in cash and an additional ~$26.0M in contingent consideration upon the achievement of regulatory […]
Chicago-based Help at Home has acquired Prime Home Care, an in-home care provider that offers both home health and home care services across nine Ohio […]
After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma […]
Shots: Organon to acquire Forendo for a total consideration of $954M including $75M up front, $9M in Forendo debt, $270M upon the achievement of development […]
In summer, hardly a week went by where Choice Health at Home wasn’t in the headlines. Founded in 2007 by David Jackson, a licensed physical […]
Shots: Coloplast to acquire Atos Medical for an enterprise value of $2.49B from PAI Partners. The transaction is expected to close in Q2’22 Coloplast obtains […]
The Pennant Group Inc. (Nasdaq: PNTG) has fallen short of its own goals. At the top of the company’s earnings call Tuesday, Pennant CEO Danny […]
Shots: BAC signs a merger agreement with Blade for an enterprise value of ~$352.8M based on 58M in shares of common stock. Blade Therapeutics will […]
Paris-based Cardiologs has a software platform to screen for arrhythmias from ECG data. It would add to Philips’ portfolio of cardiac software for hospitals and […]
Shots: Ivantis to receive $475M up front along with additional payments upon achievement of regulatory & commercial milestones. The transaction is expected to close in […]
Switzerland’s Social Democratic Party has argued that the government should step in and acquire Novartis’ generics unit Sandoz if the company decides to sell it, […]
HouseWorks announced Thursday that it has signed an agreement to acquire Connected Home Care, a home care provider that operates in Eastern Massachusetts. The Connected […]
After more than 20 years, Novartis has finally decided to sell its substantial share in fellow Swiss pharma group Roche for $20.7 billion, a decent […]
The companies have certified substantial compliance with a request for additional information from the Department of Justice, which opened an investigation of the merger in […]
Shots: Codiak to receive $65M of in-kind manufacturing services for its clinical-stage programs and hold its pipeline of therapeutic candidates along with exosome engineering and […]
In terms of financial results, Addus HomeCare Corporation (Nasdaq: ADUS) is coming off a record third quarter. The Frisco, Texas-based home health, hospice and personal […]
Home-focused software and technology company AlayaCare has acquired Delta Health Technologies, a provider of home health solutions. Traditionally a home care software enabler, this acquisition […]
Agile, nimble entrepreneurs with a vision can often chart a course through the big guys to serve emerging needs or those that rarely get attention
Japanese drugmaker Takeda has said it will exercise its option to buy UK-based GammaDelta Therapeutics, a specialist in ‘off-the-shelf’ cell therapies for solid tumours and […]
Shots: Takeda exercises its option to acquire GammaDelta which includes up front along with development and regulatory milestones. The acquisition is expected to be close […]
Over two years after spinning off from The Ensign Group (Nasdaq: ENSG), Eagle, Idaho-based The Pennant Group (Nasdaq: PNTG) stands at 87 home health and […]
When putting together a list of home health giants, Intrepid USA Healthcare Services sometimes gets overlooked. The Texas-based Intrepid USA has more than 60 locations […]
Novartis revealed today that it may consider divesting its generic medicines subsidiary Sandoz – amongst other options – which would further narrow its focus to […]
The independent home care company HouseWorks has acquired Atlantic Homelife Senior Care. Financial terms of the transaction were not disclosed. Headquartered in Boston, HouseWorks offers […]
Private equity firm Wellspring Capital Management has reached a deal to acquire Caring Brands International, the parent company of Sunrise, Florida-based Interim HealthCare. The deal, […]
A greater supply of home health and home care businesses is fueling an increase in dealmaking activity, according to the latest M&A update from advisory […]
Activist investors are pushing back against Merck & Co’s recent $11.5 billion deal to acquire Acceleron Pharma, arguing that its $180-per-share offer seriously undervalues the […]
In August, home care technology company Honor announced it acquired Home Instead Senior Care, one of the largest in-home aging services providers in the world. […]
TEAM Services Group – a portfolio company of the “anti-private equity firm” Alpine Investors – has acquired 24 Hour Home Care. The exact details of […]
Shots: Hologic to acquire Bolder Surgical for ~$160M which is a provider of advanced energy vessel sealing surgical devices. The acquisition is expected to be closed by […]
Walgreens Boots Alliance (Nasdaq: WBA), the holdings company for pharmacy store giant Walgreens, announced two major investments in home-based care on Thursday. The investments kick […]
Best Buy (NYSE: BBY) has signed an agreement to acquire the home-focused technology platform Current Health in an effort “to help make home the center […]
Supernus has boosted its position in central nervous system therapies with a $400 million deal to acquire Adamas Pharma that will add two approved Parkinson’s […]
Shots: Pacira Signs a definitive agreement to acquire Flexion for $8.50/share in cash along with one non-tradeable CVR of ~$8.00/share in cash upon the achievement […]
The merger of the two patient engagement companies will create an organization with more than 2,000 employees. The deal would expand Virgin Pulse’s channels for […]
Shots: Supernus signs a definitive agreement to acquire Adamas for $8.10/ share in cash (~$400M) & 2 non-tradable CVR of ~$1.00 00/share in cash (~$50M) […]
Home Health, hospice and personal care dealmaking has continued its fast pace throughout 2021 after a COVID-19-induced dry spell last year. As the industry looks […]
Shots: Boston has entered into a definitive agreement to acquire Baylis for $1.75B up front. The transaction is anticipated to close in Q1’22 The acquisition […]
Shots: Inotiv to acquire Plato BioPharma for $15.0M that consist of $10.0M in cash, $2.0M in Inotiv’s common shares (57,587) based on the average closing […]
Aveanna Healthcare (Nasdaq: AVAH) has agreed to acquire Comfort Care Home Health for $345 million, according to financial filings. The Atlanta-based Aveanna went public through […]
Private equity firm Pharos Capital Group has acquired THEMA Health Services, a home health and palliative care provider that operates across Arizona. The financial terms […]
Walgreens is considering buying Evolent Health, which makes software to help providers manage their value-based care programs, according to a recent report by Bloomberg. Evolent’s […]
Shots: Merck to acquire Acceleron for $180/share in cash making a total equity value of ~$11.5B representing a premium of 2.6% to the stock’s closing […]
After days of speculation, Merck & Co confirmed today that it has agreed to acquire Acceleron Pharma $1.5 billion, setting up what could be one […]
Shots: Alexion has exercised its option to acquire all remaining equity in Caelum for CAEL-101 which is currently being evaluated in P-III CARES clinical program […]
AstraZeneca’s newly acquired Alexion will buy the remaining equity in rare disease specialist Caelum Biosciences in a deal that could be worth up to $500 […]
Medical technology companies saw 288 deals between June 2020 and June 2021, the highest amount ever since Ernst & Young began tracking it in 2007. […]
A new blank-check company is hunting for aging-in-place businesses to take public. And unlike other senior care-related special purpose acquisition companies (SPACs) launched in the […]
US biopharma company Acceleron is the next company heading for a takeover by a big pharma group – according to a Bloomberg report citing people […]
Shots: GE has signed an agreement to acquire BK Medical for $1.45B in cash and is eligible to receive a high-single-digit return on invested capital […]
The LHC Group Inc. (Nasdaq: LHCG) M&A run continues. The Lafayette, Louisiana-based company recently announced agreements to acquire Generations Home Health along with Freda H. […]
It’s been quite a while since Jess & I did a Health in 2 Point 00 and that one was buried in our Policies|Techies|VCs conference […]
Boehringer Ingelheim says it has agreed to buy US biotech Abexxa Biologics, its second acquisition in the cancer immunotherapy area in the space of a […]
Shots: The acquisition includes upfront, milestones, and other consideration payments. Abexxa will continue to operate in the Arlington The acquisition will allow Boehringer to access […]
Walgreens Boots Alliance (Nasdaq: WBA) plans to invest $970 million in Shields Health Solutions, which aids both hospitals and health systems with specialty pharmacy services. […]
Shots: Boston currently holds ~16% equity stake in Devor & acquires the remaining 84% for ~$269M up front and ~$67M upon achievement of clinical & […]
Shots: The acquisition expands Novartis’ ophthalmology portfolio with the addition of Arctos’ pre-clinical optogenetics-based AAV gene therapy program and its technology The acquisition marks the […]
Tobacco giant Philip Morris International (PMI) has won the shareholder vote it needed for its controversial £1.1 billion takeover of respiratory drugmaker Vectura, despite mobilised […]
After closing a series C round led by 8VC, Flywheel used a portion of the funds to acquire St. Louis-based Radiologics. Both have platforms to […]
Often in the home-based care field, transactions are driven by companies seeking to expand their service lines to become one-stop shops for referral partners. Sometimes, […]
Shots: AbCellera acquires TetraGenetics in an all-cash transaction that includes up front, milestones based on the achievement of technical milestones related to the development of […]
Shots: The merger was approved in a shareholder vote with 75% participation & 97% in favor of the combination. Upon the closing of the merger, […]
Shots: AzurRx to acquire First Wave Bio for $229M in cash & stock including development, regulatory & sales milestones. The transaction is anticipated to close […]
The Pennant Group Inc. (Nasdaq: PNTG) has purchased the assets of Amarillo, Texas-based Open Heart Hospice. The financial terms of the deal were not disclosed. […]
Shots: ZOLL Medical to acquire all outstanding ordinary shares of Itamar Medical for $31/ADS or $1.03/ordinary share in cash making a total deal value of […]
Shots: Roche has signed a purchase agreement to acquire 100% of the outstanding shares of the TIB. The transaction is expected to close in Q4’21 […]
In the U.S. Centers for Medicare & Medicaid Services’ (CMS) proposed payment rule for 2022, the attention-grabber was the expansion of the Home Health Value-Based […]
Shots: Smiths to receive 2.5M at closing in cash and stock which is currently valued at ~$500M, $1.85B in cash along with liabilities & is […]
LHC Group Inc. (Nasdaq: LHCG) has already hit a record year for M&A activity. It added to its streak in a major way on Wednesday, […]
Less than a month after Kadmon Pharma launched its first product – Rezurock for a complication of organ transplants – the New York company has […]
Shots: Sanofi to acquire Kadmon for $9.50/share in cash making a total equity value of ~ $1.9B with a premium of 79% to a closing […]
French biopharma company Hybrigenics has made another bid to merge with Belgium’s Bone Therapeutics, a specialist in regenerative medicine that is still recovering from a […]
Shots: Advent and GIC to acquire Sobi for ~$8B (SEK 69.4B) at $27.33/share (SEK 235) representing a premium of 34.5% to the closing price of […]
Trive Capital, a Dallas-based private equity firm, has formed a partnership with Choice Health at Home. Tyler, Texas-based Choice is a home health, hospice and […]
Shots: The acquisition will accelerate Abbott’s vascular portfolio with the addition of Walk Vascular’s peripheral thrombectomy systems to treat patients with peripheral blood clots Walk […]
Shots: Baxter to acquire Hillrom for $156.00/ share in cash making a total equity value of ~$10.5B representing a premium of 26% to the stock’s […]
The home health market has been a hotbed of M&A activity as of late, and there are a number of key factors sparking the dealmaking […]
The home health company PathWell began as a technology company aiming to help other operators with back-end issues. But when COVID-19 hit, it changed direction […]
Shots: Baxter in talks to acquire Hill-Rom for ~$10B with $150/ share representing a premium of 13% to the stock’s closing price of $132.90. The […]
A merger between two digital mental health companies – Headspace and Ginger – will create a $3 billion giant in a category that has been […]
It’s M&A day here on Health in 2 Point 00! On Episode 229, Jess and I chat about the big news that Headspace and Ginger […]
Pfizer is the latest big pharma company to take a position on drugs that target CD47 – a ‘don’t eat me’ signal that protects cancer […]
Shorts: Pfizer will acquire all outstanding shares of Trillium for $18.50/share in cash making a total equity value of $2.26B with 203.8% premium on the […]
A Medivation executive at the heart of the company’s team that sold the company to Pfizer for $14 billion five years ago is facing allegations […]
Alivia’s new home health transaction Alivia Care Inc. has acquired Summerfield, Florida-based home health provider Better Life Home Health. Financial terms were not disclosed. Alivia […]
Interest in acquisitions, mergers and joint venture arrangements continues to heat up in the home health space. But for every successful deal that’s closed, there’s […]
In the wake of going public in the spring, the leadership team at Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has been especially vocal about its […]
Investors had long expected Intersect ENT to be an acquisition target before Medtronic announced its plans to buy the company last week. Better reimbursement for […]
Last year, CareLinx entered a new phase of its business with its entrance into the clinical side of home-based care. As a result, CareLinx saw […]
The Pennant Group Inc.’s (Nasdaq: PNTG) position is different from other, larger home health companies in the country, mainly in that a substantial portion of […]
Private equity group Carlyle has said it won’t raise its offer for respiratory drug specialist Vectura to match a 165p per share offer from tobacco […]
Shots: Harmony to receive $3.5M up front & development and regulatory milestone along with royalties & will acquire full development and commercialization rights globally, Ex- […]
Brookdale Senior Living Inc. (NYSE: BKD) used to be one of the largest home health providers in the country, thanks to its health services segment. […]
In the past year, ModivCare Inc. (Nasdaq: MODV) has hit the ground running in the home-based care space. With recent acquisitions, the company is further […]
Copyright © 2024 | WordPress Theme by MH Themes